Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angong Niuhuang Pill therapeutic effect evaluation in acute febrile or comatose patients
ChiCTR2000030368Phase 4Recruiting
- Sponsor
- Emergency Department of Shanxi Hospital of Traditional Chinese Medicine
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Angong Niuhuang Pill in ischemic stroke, encephalitis, meningitis and 5 more, sponsored by Emergency Department of Shanxi Hospital of Traditional Chinese Medicine. Primary endpoints: Changes in body temperature and duration of hyperthermia/fever, Outcome and time needed for wake up and coma correction and 4 more. Started Oct 2019; status: recruiting.
02
Drugs
Angong Niuhuang Pill
03
Conditions
ischemic strokeencephalitismeningitisToxic Metabolic Encephalopathy (TME)brain hemorrhage (ICH)
Beyond the preview
Go deeper on ChiCTR2000030368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030368.